Search results for "cardiometabolic risk"

showing 10 items of 42 documents

Lifestyle counseling to reduce body weight and cardiometabolic risk factors among truck and bus drivers – a randomized controlled trial

2015

Objectives We conducted a randomized trial among overweight long-distance drivers to study the effects of structured lifestyle counseling on body weight and cardiometabolic risk factors. Methods Men with waist circumference > 100 cm were randomized into a lifestyle counseling (LIFE, N=55) and a reference (REF, N=58) group. The LIFE group participated in monthly counseling on nutrition, physical activity, and sleep for 12 months aiming at 10% weight loss. After 12 months, the REF group participated in 3-month counseling. Assessments took place at 0, 12, and 24 months. Between-group differences in changes were analyzed by generalized linear modeling. Metabolic risk (Z score) was calculated fr…

CounselingMaleobesityprofessional driverHealth BehaviorOverweightlaw.invention0302 clinical medicineRandomized controlled triallawWeight lossRisk FactorsMeS030212 general & internal medicinemetabolinen oireyhtymäta515truck drivercardiometabolic risk factorexerciseta3141ta3142Middle Aged16. Peace & justice030210 environmental & occupational healthlifestyle counseling3142 Public health care science environmental and occupational healthSHIFT WORK3. Good healthnutritionrisk factorCARDIOVASCULAR-DISEASECardiovascular DiseasesHEALTHmedicine.symptomPublic aspects of medicineRA1-1270INTERVENTIONSAdultmedicine.medical_specialtyAutomobile DrivingWaistDiet Reducingmetabolic syndromeravinto03 medical and health sciencesbody weightwalkingInternal medicinemedicinemesCOMMERCIAL DRIVERSHumansRisk factorbusiness.industrylaihdutusPublic Health Environmental and Occupational HealthLORRY DRIVERSFeeding BehaviorOverweightmedicine.diseaseObesityConfidence intervalPHYSICAL-ACTIVITYMALE PROFESSIONAL DRIVERSrandomized controlled trialPhysical therapylihavuusMetabolic syndromeweight lossbus driverbusinessRisk Reduction Behavior
researchProduct

Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients

2022

nessuno

Diabetes Mellitus Type 1EndocrinologyNon-alcoholic Fatty Liver DiseaseEndocrinology Diabetes and MetabolismInternal MedicineHumansObesityCardiometabolic risk Diabetes mellitus type 1 Metabolic syndrome Nonalcoholic Nonalcoholic fatty liver disease Obesity SteatohepatitisJournal of Diabetes and its Complications
researchProduct

Obesity and Cardiometabolic Risk Factors : from Childhood to Adulthood

2021

Obesity has become a major epidemic in the 21st century. It increases the risk of dyslipidemia, hypertension, and type 2 diabetes, which are known cardiometabolic risk factors and components of the metabolic syndrome. Although overt cardiovascular (CV) diseases such as stroke or myocardial infarction are the domain of adulthood, it is evident that the CV continuum begins very early in life. Recognition of risk factors and early stages of CV damage, at a time when these processes are still reversible, and the development of prevention strategies are major pillars in reducing CV morbidity and mortality in the general population. In this review, we will discuss the role of well-known but also …

EpigenomicsMaleGerontologyPediatric ObesityobesityInfants Alimentacióobesity ; cardiometabolic risk factors ; hypertension ; dyslipidemia ; tracking phenomenon ; nutrigenomicsReviewType 2 diabetesnutrigenomicPregnancytracking phenomenon.TX341-641ChildPrenatal Nutritional Physiological PhenomenaMetabolic Syndromeeducation.field_of_studyNutrition and Dieteticscardiometabolic risk factorNutrigenomicsCardiorespiratory FitnessCardiovascular DiseasesChild PreschoolObesitatFemaleAdulttracking phenomenonhypertensionAdolescentPopulationChildhood obesityYoung AdultnutrigenomicsmedicineMortalitatHumansAdultseducationbusiness.industryNutrition. Foods and food supplydyslipidemiaInfant NewbornInfantCardiorespiratory fitnessmedicine.diseaseObesitycardiometabolic risk factorsDietMetabolic syndromebusinessDyslipidemiaFood Science
researchProduct

Differences in cardiometabolic risk profiles between Chinese and Finnish older adults with glucose impairment and central obesity.

2022

Abstract Background Obesity and ethnicity play important roles in cardiovascular complications in patients with type 2 diabetes mellitus (T2DM). This study aimed to compare cardiometabolic risk profiles between Chinese and Finnish older adults of central obesity with prediabetes or T2DM. Methods Study subjects were 60–74 years old and originated from two population samples. The Finnish subjects came from the Kuopio Ischemic Heart Disease (KIHD) study (n = 1089), and the Chinese subjects came from the Shanghai High-risk Diabetic Screen (SHiDS) study (n = 818). The KIHD and SHiDS studies used similar questionnaires to determine participants’ baseline characteristics regarding the history of m…

GerontologyBlood GlucoseChinaEndocrinology Diabetes and MetabolismEndocrinology and DiabetesPrediabetic StateEndocrinologyRisk FactorsType 2 diabetes mellitusEthnicitymedicineHumanssuomalaisetObesityFinlandTriglyceridesAgedCardiometabolic riskChinesebusiness.industryFinnishCholesterol HDLriskitekijätMiddle AgedkiinalaisetCardiovascular disease riskmedicine.diseaseObesityGlucoseDiabetes Mellitus Type 2Cardiovascular DiseasesCentral obesityObesity AbdominalEndokrinologi och diabetessydän- ja verisuonitauditlihavuusInsulin Resistancebusinessaikuistyypin diabetesJournal of endocrinological investigation
researchProduct

Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us

2022

As the world enters its third year of the COVID-19 pandemic, individuals with diabetes have faced particular challenges from the virus. A deleterious bidirectional relationship exists between the two disorders, with heightened inflammatory, immunologic, and cellular mechanisms leading to a more severe illness and increased morbidity and mortality. Tight glucose control, though necessary, is hampered by physical restrictions and difficulty accessing health care. Novel glucose-lowering medications may provide unique benefits in this regard. It is imperative that multi-pronged efforts be prioritized in order to reduce adverse outcomes in patients with diabetes at risk for COVID-19.

GlucoseCOVID-19 cardiometabolic risk complications diabetes obesity treatmentSARS-CoV-2Endocrinology Diabetes and MetabolismDiabetes MellitusInternal MedicineCOVID-19HumansPandemicsMetabolic Syndrome and Related Disorders
researchProduct

Blood cell transcript levels in 5-year-old children as potential markers of breastfeeding effects in those small for gestational age at birth

2019

BackgroundNutrition of the newborn during the early postnatal period seems to be of capital importance and there is clinical evidence showing the protective effect of breastfeeding compared with formula feeding on childhood obesity and its comorbidities. Infants born small for gestation age may be more sensitive to the type of feeding during lactation. Here, we aimed to analyze the impact of birth weight and the type of infant feeding on the expression levels in peripheral blood cells of selected candidate genes involved in energy homeostasis in 5-year-old children, to find out potential early biomarkers of metabolic programming effects during this period of metabolic plasticity.MethodsFort…

Male0301 basic medicinehumanosBreastfeedingPhysiologylcsh:MedicineSangBlood Pressureregulación de la expresión génicalactancia materna0302 clinical medicineLactationBirth Weightcélulas sanguíneasGeneral MedicineARNmedicine.anatomical_structureBreast FeedingChild Preschool030220 oncology & carcinogenesisInfant Small for Gestational AgeInfant formulaGestationFemaleInfantspresión sanguíneaBreast milkSystoleBirth weightBreast milkGeneral Biochemistry Genetics and Molecular BiologyChildhood obesity03 medical and health sciencessístoleMetabolic programmingmedicineHumansRNA Messengerpeso al nacerlactanteBlood Cellsbusiness.industryResearchlcsh:RInfant NewbornInfantmedicine.diseaseCardiometabolic risk factors030104 developmental biologyInfant formulaGene Expression RegulationSmall for gestational ageRNAbusinessBiomarkers
researchProduct

Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: a randomized, controlled trial.

2011

Objectives: Apolipoprotein (Apo)B, ApoA-I, and their ratio could predict coronary heart disease (CHD) risk more accurately than conventional lipid measurements. Our aim was to assess the effect of a traditional Mediterranean diet (TMD) on apolipoproteins. Methods: High-cardiovascular risk subjects (n=551, 308 women and 243 men), aged 55-80 years, were recruited into a large, multicenter, randomized, controlled, parallel-group, clinical trial (The PREDIMED Study) aimed at testing the efficacy of TMD on primary cardiovascular disease prevention. Participants assigned to a low-fat diet (control) (n=177), or TMDs (TMD. +. virgin olive oil (VOO), n=181 or TMD. +. nuts, n=193) received nutritiona…

MaleApolipoprotein BMediterranean dietCoronary DiseaseDiet MediterraneanDieta mediterràniaApolipoprotein B/A-I ratiolaw.inventionCohort StudiesRandomized controlled triallawVirgin olive oilMedicineNutsCardiometabolic riskAged 80 and overBioquímica y tecnologíabiologyAnthropometryMiddle AgedLipidsBiochemistry and technology0021-9150virgin olive oilApolipoproteïnesFemalelipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineApolipoprotein BCohort studyRiskmedicine.medical_specialtyApolipoprotein B/A-IBioquímica i biotecnologiaInternal medicineMediterranean dietHumansPlant OilsOlive OilAgedApolipoproteins BApolipoprotein A-Ibusiness.industrynutritional and metabolic diseasesApolipoproteins bCardiometabolic riskClinical trialEndocrinologybiology.proteinbusinessOlive oil
researchProduct

Twelve Months of Time-restricted Eating and Resistance Training Improves Inflammatory Markers and Cardiometabolic Risk Factors.

2021

Introduction Recently, a modified intermittent fasting protocol was demonstrated to be able to maintain muscle mass and strength, decrease fat mass, and improve some inflammation and cardiovascular risk factors in healthy resistance-trained males after 2 months. The present study sought to investigate the long-term effects on these parameters. Methods The experiment was a single-blind randomized study. Twenty healthy subjects were enrolled and underwent 12 months of either a time-restricted eating (TRE) diet or a normal diet (ND) protocol, along with resistance training. In the TRE protocol, subjects consumed their energy needs in three meals during an 8-h period of time each day (1 pm, 4 p…

MaleCalorieNormal dietmedicine.medical_treatmentPhysiologyPhysical Therapy Sports Therapy and RehabilitationBody Mass Indexchemistry.chemical_compoundInsulin resistanceIntermittent fastingmedicineHumansOrthopedics and Sports MedicineSingle-Blind MethodInsulin-Like Growth Factor IAdipositymedicine.diagnostic_testCholesterolbusiness.industryInsulinCardiometabolic Risk FactorsResistance TrainingFastingmedicine.diseasechemistryHomeostatic model assessmentInsulin ResistanceLipid profilebusinessEnergy IntakeMedicine and science in sports and exercise
researchProduct

Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian S…

2011

Abstract Background The Visceral Adiposity Index (VAI) is a sex-specific mathematical index, based on Waist Circumference (WC), Body Mass Index (BMI), triglycerides (TG) and HDL cholesterol (HDL) levels, indirectly expressing visceral adipose function and insulin sensitivity. Our aim was to find the optimal cut-off points of VAI identifying a visceral adipose dysfunction (VAD) associated with cardiometabolic risk in a Caucasian Sicilian population. Methods Medical check-up data of 1,764 Primary Care patients (PC patients) were retrospectively and cross-sectionally examined using a receiver-operating characteristic (ROC) curve to determine appropriate stratified-for-age cut-off of VAI, for t…

MaleCross-sectional studyEndocrinology Diabetes and MetabolismClinical BiochemistrySettore MED/13 - EndocrinologiaEndocrinologyReference ValuesRisk Factorscardiometabolic riskPrevalenceMyocardial infarctionSicilylcsh:RC620-627Aged 80 and overMetabolic Syndromeeducation.field_of_studyMiddle Agedlcsh:Nutritional diseases. Deficiency diseasesCardiovascular DiseasesCardiologyvisceral adipose dynsfunctionFemaleAdultmedicine.medical_specialtyWaistAdolescentPopulationVisceral adiposity index VAI Obesity cardiometabolic risk visceral adipose dynsfunctionClinical nutritionIntra-Abdominal FatWhite PeopleYoung AdultInternal medicineDiabetes mellitusmedicineHumansBody Weights and MeasuresObesitycardiovascular diseaseseducationAgedRetrospective StudiesBiochemistry medicalbusiness.industryResearchBiochemistry (medical)medicine.diseaseVAIEndocrinologyCross-Sectional StudiesDiabetes Mellitus Type 2Metabolic syndromebusinessBody mass indexLipids in Health and Disease
researchProduct

Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study

2018

Purpose: Patients with Cushing’s disease (CD) experience metabolic alterations leading to increased cardiovascular mortality. Recently, the visceral adiposity index (VAI) has been proposed as a marker of visceral adipose tissue dysfunction (ATD) and of the related cardiometabolic risk. We aimed to evaluate the impact of 12-month pasireotide treatment on cardiometabolic risk in CD patients. Methods: This is a multicentre, prospective, and observational study. Sixteen CD patients, referred to the Endocrine Units of the University Hospitals of Messina, Napoli, Padova, and Palermo (Italy), successfully treated with pasireotide for 12 month have been enrolled. In all patients, we assessed anthro…

MaleEndocrinology Diabetes and MetabolismCardiometabolic risk Cushing’s disease hypercortisolism pasireotide visceral adiposity indexLongitudinal StudieDisease030204 cardiovascular system & hematologySettore MED/13 - Endocrinologiachemistry.chemical_compound0302 clinical medicineEndocrinologyRisk FactorsMedicineLongitudinal StudiesProspective StudiesAdiposityFramingham Risk ScoreCushing’s diseaseCushing’s diseaseMiddle AgedPasireotideDiabetes and MetabolismHeart DiseaseItalyAtherosclerosiObesity AbdominalFemaleSomatostatinHumanAdultmedicine.medical_specialtyWaistHeart DiseasesHypercortisolism030209 endocrinology & metabolismIntra-Abdominal Fat03 medical and health sciencesMetabolic DiseasesInternal medicineDiabetes mellitusCardiometabolic risk; Cushing’s disease; Hypercortisolism; Pasireotide; Visceral adiposity index; Endocrinology Diabetes and Metabolism; EndocrinologyHumansPituitary ACTH Hypersecretionbusiness.industryRisk FactorCushing's diseaseAnthropometryAtherosclerosismedicine.diseasePasireotideCardiometabolic riskMetabolic DiseaseVisceral adiposity indexProspective StudiechemistryObservational studybusiness
researchProduct